Fluorinated Cell Surfaces to Modulate Biological Function
Fluorinated Cell Surfaces to Modulate Biological Function
批准号:
7467843
负责人:
KRISHNA KUMAR
金额:
$37.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2012-04-30
关键词:
AdhesionsBiologicalBiological AssayBiological ProcessCarbohydratesCell AdhesionCell physiologyCell surfaceCellsCharacteristicsCleaved cellCultured CellsDiseaseFluorineGlycocalyxGlycolipidsGlycoproteinsGoalsImageImaging TechniquesIn VitroIncubatedInflammationInflammatoryInterest GroupInvasiveLifeMagnetic Resonance ImagingMediatingModelingModificationMusNatureNeoplasm MetastasisProcessPropertyPublic HealthRateReactionSialic AcidsSpectrometry, Mass, Secondary IonSurfaceTechniquesanalogcancer diagnosiscancer therapychemical geneticsdesignhuman diseaseneoplastic celltumor
中文摘要
描述(申请人提供):拟议研究的目标是探索活细胞的生物学和生物物理性质,这些细胞表面装饰有非天然的含氟碳水化合物。已经发现,这种细胞表面修饰减少了细胞黏附,因此可能提供一种手段来治疗由细胞黏附介导的人类疾病过程,如肿瘤转移和炎症。该项目的一部分是为了确定细胞表面氟修饰对与细胞黏附相关的生物功能的影响。氟化唾液酸降低肿瘤转移率或转移程度的能力将在小鼠模型中通过生物发光成像进行研究。将氟化分子附着到细胞表面是通过将细胞与化学合成的氟化唾液酸类似物孵育完成的,这些类似物被吸收并加工成表达在细胞糖萼上的氟化糖蛋白和糖脂。这个项目的一部分是确定在细胞表面表达氟化唾液酸类似物的结构要求是什么。此外,细胞表面修饰分子的分布和性质将通过二次离子质谱仪、选择性裂解的细胞表面分子的比色分析和化学遗传学方法来确定。由于在未经修饰的细胞中几乎不存在氟化分子,氟原子的加入为非侵入性技术的低本底成像提供了机会。用氟化唾液酸治疗的荷瘤小鼠将用19F磁共振成像。由于许多肿瘤细胞是超唾液酸化的,这项技术可能有助于在肿瘤通过其他方法可见之前定位它们。本研究的具体目的是:(1)确定培养细胞上表达的氟化唾液酸类似物的耐受范围;(2)评估表达氟化唾液酸的细胞的静态黏附特性,并研究黏附改变的机制;(3)表征表达氟化糖的细胞表面;(4)评价细胞表面氟化对小鼠肿瘤转移的影响;(5)评价表达氟化糖的荷瘤小鼠的19F MRI。公共卫生相关性:这项拟议的研究与癌症治疗相关,并可能与炎症性疾病相关,因为它探索了一种减少细胞黏附的新策略。这项研究也与癌症诊断相关,因为它可能提供一种通过核磁共振成像肿瘤的方法。
英文摘要
DESCRIPTION (provided by applicant): The goal of the proposed study is to explore the biological and biophysical properties of living cells that are decorated with unnatural fluorinated carbohydrates on their surfaces. It has been found that this cell-surface modification reduces cell adhesion, and therefore may provide a means to treat human disease processes that are mediated by cell adhesion such as tumor metastasis and inflammation. Part of this project is designed to determine the effect of cell-surface fluorine modification on biological functions related to cellular adhesion. The ability of fluorinated sialic acids to reduce the rate or extent of tumor metastasis will be studied by bioluminescent imaging in a murine model. The attachment of fluorinated molecules to the cell surface is accomplished by incubating the cells with chemically synthesized fluorinated sialic acid analogues that are taken up and processed into fluorinated glycoproteins and glycolipids expressed on the cell glycocalyx. Part of this project is to determine what the structural requirements are for a fluorinated sialic acid analogue to be expressed on the cell surface. Also, the distribution and nature of modified molecules on the cell surface will be determined by secondary ion mass spectrometry, by colorimetric assay of selectively cleaved cell-surface molecules, and by a chemical genetics approach. Since fluorinated molecules are virtually absent in unmodified cells, the incorporation of fluorine atoms provides an opportunity for low-background imaging by non-invasive techniques. Tumor bearing mice treated with fluorinated sialic acids will be imaged by 19F MRI. Since many tumor cells are hypersialylated, this technique may be useful for locating tumors before they are visible by other means. The Specific Aims for this study are to: (1) determine the scope of fluorinated sialic acid analogues tolerated for expression on cultured cells; (2) evaluate the static adhesion characteristics of cells expressing fluorinated sialic acids and study the mechanism of altered adhesion; (3) characterize the surfaces of cells expressing fluorinated carbohydrates; (4) evaluate the effect of cell-surface fluorination on tumor metastasis in mice; and (5) evaluate 19F MRI of tumor-containing mice expressing fluorinated carbohydrates. PUBLIC HEALTH RELEVANCE: The proposed study is relevant to cancer therapy and potentially to inflammatory disease because it explores a new strategy for reducing cell adhesion. The study is also relevant for cancer diagnosis because it may provide a way to image tumors by MRI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protease Stable N-Terminally Modified Therapeutic Peptides
-
批准号:10484456
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2022
-
负责人:KRISHNA KUMAR
-
依托单位:
Triagonist Peptide Therapeutics for Neuroprotection
-
批准号:10326283
-
项目类别:
-
资助金额:$25.96万
-
财政年份:2021
-
负责人:KRISHNA KUMAR
-
依托单位:
High-Purity Peptide Libraries without Chromatographic Separation
-
批准号:8715569
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:KRISHNA KUMAR
-
依托单位:
Stabilization of Therapeutic Peptides by Non-Perturbative Chemical Modification
-
批准号:8782447
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:KRISHNA KUMAR
-
依托单位:
Fluorinated Cell Surfaces to Modulate Biological Function
-
批准号:8071987
-
项目类别:
-
资助金额:$43.83万
-
财政年份:2008
-
负责人:KRISHNA KUMAR
-
依托单位:
Fluorinated Cell Surfaces to Modulate Biological Function
-
批准号:7618471
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2008
-
负责人:KRISHNA KUMAR
-
依托单位:
Fluorinated Cell Surfaces to Modulate Biological Function
-
批准号:7807929
-
项目类别:
-
资助金额:$45.26万
-
财政年份:2008
-
负责人:KRISHNA KUMAR
-
依托单位:
New Theraputics for Graft-Versus-Host Disease
-
批准号:7055781
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2006
-
负责人:KRISHNA KUMAR
-
依托单位:
ANALYTICAL ULTRACENTRIFUGE: BONE FORMATION
-
批准号:6973233
-
项目类别:
-
资助金额:$3.27万
-
财政年份:2004
-
负责人:KRISHNA KUMAR
-
依托单位:
ANALYTICAL ULTRACENTRIFUGE: PROTEINS: FORMATION, STRUCTURE, FUNCTION & INTERACTI
-
批准号:6973234
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2004
-
负责人:KRISHNA KUMAR
-
依托单位:
ANALYTICAL ULTRACENTRIFUGE:PROTEIN & NEURODEGENERATIVE DIS: ALZHEIMER, PARKINSON
-
批准号:6973232
-
项目类别:
-
资助金额:$9.82万
-
财政年份:2004
-
负责人:KRISHNA KUMAR
-
依托单位:
Beckman XL-I Analytical Ultracentrifuge
-
批准号:6733291
-
项目类别:
-
资助金额:$32.72万
-
财政年份:2004
-
负责人:KRISHNA KUMAR
-
依托单位:
Protein Design Using Unnatural Amino Acids
-
批准号:7322611
-
项目类别:
-
资助金额:$27.94万
-
财政年份:2002
-
负责人:KRISHNA KUMAR
-
依托单位:
Protein Design Using Unnatural Amino Acids
-
批准号:7471372
-
项目类别:
-
资助金额:$29.21万
-
财政年份:2002
-
负责人:KRISHNA KUMAR
-
依托单位:
Ion Channel Design Using Unnatural Amino Acids
-
批准号:6623462
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2002
-
负责人:KRISHNA KUMAR
-
依托单位:
Ion Channel Design Using Unnatural Amino Acids
-
批准号:6744162
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2002
-
负责人:KRISHNA KUMAR
-
依托单位:
Protein Design Using Unnatural Amino Acids
-
批准号:7666859
-
项目类别:
-
资助金额:$29.21万
-
财政年份:2002
-
负责人:KRISHNA KUMAR
-
依托单位:
Ion Channel Design Using Unnatural Amino Acids
-
批准号:7060733
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2002
-
负责人:KRISHNA KUMAR
-
依托单位:
Ion Channel Design Using Unnatural Amino Acids
-
批准号:6892357
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2002
-
负责人:KRISHNA KUMAR
-
依托单位:
Ion Channel Design Using Unnatural Amino Acids
-
批准号:6466001
-
项目类别:
-
资助金额:$26.32万
-
财政年份:2002
-
负责人:KRISHNA KUMAR
-
依托单位:
海外基金